Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

OPK

OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research

1.51 +1.3% mkt cap $1.13B quote delayed (FMP) · as of Aug 26 21:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
12Tracked holders
+1Δ holders
38.88MShares held
$64.54MReported value
+2New positions
−1Exits
Strongly Rising Conviction score 67/100 3 quarters of rising tracked shares ●●●○○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +9.1% · share flow +29.5% · net new positions +8.3%formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 83 -5 114.41M $171.44M +3 −8
Q1 2026 91 +2 116.06M $132.34M +8 −6
Q4 2025 88 0 132.71M $167.24M +1 −1
Q3 2025 15 -2 100.01M $155.02M −3
Q2 2025 15 0 96.47M $127.34M +2 −2
Q1 2025 12 +1 38.88M $64.54M +2 −1
Q4 2024 11 -1 30.02M $44.13M −1
Q3 2024 11 +1 16.46M $24.53M +1
Q2 2024 10 13.40M $16.75M
Holder count
Who holds it · Q1 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 Geode Capital Management (passive) 8.43M +0.5% $14.00M 0.0% ▲ Add 4 SEC ↗
2 Geode Capital Management (passive) 8.43M +0.5% $14.00M 0.0% ▲ Add 4 SEC ↗
3 State Street Global Advisors (passive) 8.14M -10.3% $13.51M 0.0% ▼ Trim 2 SEC ↗
4 Millennium Management 6.39M +39.2% $10.60M 0.0% ▲ Add 4 SEC ↗
5 Marshall Wace 4.90M +431.4% $8.13M 0.0% ▲ Add 3 SEC ↗
6 Marshall Wace 4.90M +431.4% $8.13M 0.0% ▲ Add 3 SEC ↗
7 D. E. Shaw & Co. 4.73M New $7.85M 0.0% New 1 SEC ↗
8 Citadel Advisors 1.86M -42.2% $3.08M 0.0% ▼ Trim 4 SEC ↗
9 Citadel Advisors 1.86M -42.2% $3.08M 0.0% ▼ Trim 4 SEC ↗
10 Two Sigma Investments 1.65M -0.1% $2.73M 0.0% ▼ Trim 4 SEC ↗
11 Two Sigma Investments 1.65M -0.1% $2.73M 0.0% ▼ Trim 4 SEC ↗
12 AQR Capital Management 1.61M +466.7% $2.67M 0.0% ▲ Add 4 SEC ↗
13 AQR Capital Management 1.61M +466.7% $2.67M 0.0% ▲ Add 4 SEC ↗
14 AQR Capital Management 1.61M +466.7% $2.67M 0.0% ▲ Add 4 SEC ↗
15 AQR Capital Management 1.61M +466.7% $2.67M 0.0% ▲ Add 4 SEC ↗
16 AQR Capital Management 1.61M +466.7% $2.67M 0.0% ▲ Add 4 SEC ↗
17 T. Rowe Price 501.67K +10.1% $833,000 0.0% ▲ Add 4 SEC ↗
18 Norges Bank (passive) 494.26K -56.2% $820,467 0.0% ▼ Trim 4 SEC ↗
19 GAMCO Investors 175.00K 0.0% $290,500 0.0% Held 4 SEC ↗
20 Gotham Asset Management 11.06K New $18,353 0.0% New 1 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

D. E. Shaw & Co. $7.85M 0.0%
Gotham Asset Management $18,353 0.0%

Exited

Renaissance Technologies $214,586 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 231 holders, 200.30M shares, $226.79M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q1 2025 · Methodology · Get this via the API